TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/24 19:08 | 1/6/24 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Lizzul Paul F. | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 6 | 155 | 10 | D | ||||||||||||||
1/9/24 19:08 | 1/8/24 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Lizzul Paul F. | CA | O | Chief Me | S.d | -56 | 21.81 | 0 | -3 | -20 | 10 | D | ||||||||||||||
9/18/23 18:14 | 9/14/23 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Lizzul Paul F. | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 6 | 999% | 7 | D | ||||||||||||||
9/18/23 18:14 | 9/14/23 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Lizzul Paul F. | CA | O | Chief Me | S.d | -41 | 19.48 | 0 | -2 | -24 | 7 | D | ||||||||||||||
8/1/17 16:23 | 8/1/17 | SNNA | Sienna Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lizzul Paul F. | CA | O | Chief Me | P.d | 150 | 15.00 | 0 | 10 | 11 | 105 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |